Back to Search
Start Over
Special editorial: When prescribing Janus kinase inhibitors for dermatologic conditions, be mindful of the Food and Drug Administration's September 1, 2021, data safety communication
- Source :
- Journal of the American Academy of Dermatology. 86:42-43
- Publication Year :
- 2022
- Publisher :
- Elsevier BV, 2022.
- Subjects :
- Ruxolitinib
medicine.medical_specialty
Tofacitinib
Alopecia Areata
United States Food and Drug Administration
business.industry
Communication
Janus Kinase 1
Dermatology
Atopic dermatitis
Alopecia areata
medicine.disease
United States
Food and drug administration
Psoriasis
Humans
Janus Kinase Inhibitors
Medicine
business
Janus kinase
Janus Kinases
Janus kinase inhibitor
medicine.drug
Subjects
Details
- ISSN :
- 01909622
- Volume :
- 86
- Database :
- OpenAIRE
- Journal :
- Journal of the American Academy of Dermatology
- Accession number :
- edsair.doi.dedup.....913d395adfc09f2d37a452a2176a2f53